急性冠脉综合征后停用双联抗血小板治疗与心血管事件
该回顾性观察队列纳入2008至2013年苏格兰出院的1340例急性冠脉综合征患者,评估停用双联抗血小板治疗(DAPT)后心血管事件是否增加。结果显示DAPT期间事件率15.7%,停药后16.7%,停药早期事件率未显著升高;年龄增长、DAPT时长及未行血运重建与停药后长期事件风险相关。
要点
- ACS后停用DAPT早期心血管事件率未显著高于后续时期。
- 年龄增长与DAPT duration延长与停药后事件风险相关。
- 住院期间未行血运重建者停药后事件风险更高。
核心结论
- 在本ACS人群中,停用DAPT后早期心血管事件率较后续时期未显著增加。
- 年龄增长、DAPT时长及缺乏血运重建治疗与停药后长期随访中心血管事件风险增加相关。
研究设计与样本
- 共纳入1340例患者,62%为男性,平均年龄64.9(13.0)岁。
主要发现
- DAPT期间(平均DAPT时长175.1(155.3)天)心血管事件发生率为15.7%(n=211)。
- 停用DAPT后(平均随访2.7年)心血管事件发生率为16.7%(n=188)。
- 停药后心血管事件的独立预测因素包括年龄(HR 1.07;95%CI 1.05至1.08;p<0.001)。
- DAPT时长(HR 0.997;95%CI 0.995至0.998;p<0.001)及住院期间血运重建治疗(HR 0.58;95%CI 0.39至0.85;p=0.005)与停药后心血管事件独立相关。
临床怎么用
- ACS后停用DAPT时,应关注高龄、DAPT时长较短及未行血运重建患者的长期心血管事件风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess whether cardiovascular events are increased after cessation of dual antiplatelet therapy (DAPT) following acute coronary syndrome (ACS) and to explore predictors for recurrent events after DAPT cessation during long-term follow-up. METHODS: We did a retrospective observational cohort study. We included consecutive people with ACS who were discharged from Scottish hospitals between January 2008 and December 2013 and who received DAPT after discharge followed by antiplatelet monotherapy. The rates of cardiovascular events were assessed during each 90-day period of DAPT treatment and 90-day period after stopping DAPT. Cardiovascular events were defined as a composite of death, ACS, transient ischaemic attack or stroke. Cox regression was used to identify predictors of cardiovascular events following DAPT cessation. RESULTS: 1340 patients were included (62% male, mean age 64.9 (13.0) years). Cardiovascular events occurred in 15.7% (n=211) during the DAPT period (mean DAPT duration 175.1 (155.3) days) and in 16.7% (n=188) following DAPT cessation (mean of 2.7 years follow-up). Independent predictors for a cardiovascular event following DAPT cessation were age (HR 1.07; 95% CI 1.05 to 1.08; p<0.001), DAPT duration (HR 0.997; 95% CI 0.995 to 0.998; p<0.001) and having revascularisation therapy during the index admission (HR 0.58; 95% CI 0.39 to 0.85; p=0.005). CONCLUSIONS: The rate of cardiovascular events was not significantly increased in the early period post-DAPT cessation compared with later periods in this ACS population. Increasing age, DAPT duration and lack of revascularisation therapy were associated with increased risk of cardiovascular events during long-term follow-up after DAPT cessation.
引用
- Mazlan-Kepli W, Dawson J, Berry C, et al. Cessation of dual antiplatelet therapy and cardiovascular events following acute coronary syndrome. Heart. 2018. PMID: 30030335. doi:10.1136/heartjnl-2018-313148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。